130 related articles for article (PubMed ID: 37024421)
21. The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma.
Tan MH; Li H; Choong CV; Chia KS; Toh CK; Tang T; Tan PH; Wong CF; Lau W; Cheng C
Cancer; 2011 Dec; 117(23):5314-24. PubMed ID: 21567386
[TBL] [Abstract][Full Text] [Related]
22. External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
Marconi L; de Bruijn R; van Werkhoven E; Beisland C; Fife K; Heidenreich A; Kapoor A; Karam J; Kauffmann C; Klatte T; Ljungberg B; Matin S; Sjoberg D; Staehler M; Stewart GD; Tanguay S; Uzzo R; Welsh S; Wood L; Wood C; Bex A
World J Urol; 2018 Dec; 36(12):1973-1980. PubMed ID: 30069581
[TBL] [Abstract][Full Text] [Related]
23. External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology.
Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Rehak P; Pummer K; Zigeuner R
J Urol; 2011 Nov; 186(5):1773-7. PubMed ID: 21944989
[TBL] [Abstract][Full Text] [Related]
24. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.
Jeldres C; Sun M; Lughezzani G; Isbarn H; Shariat SF; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Cancer; 2010 Aug; 116(16):3774-84. PubMed ID: 20564085
[TBL] [Abstract][Full Text] [Related]
25. Nomograms for predicting overall and cancer-specific survival of patients with chromophobe renal cell carcinoma after nephrectomy: a retrospective SEER-based study.
Zheng J; Li S; Zhao Y; Tao Z; Li L; Li Z; Li M; Chen X
BMJ Open; 2022 Sep; 12(9):e062129. PubMed ID: 36581979
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of a Nomogram to Predict Cancer-Specific Survival in Elderly Patients With Papillary Renal Cell Carcinoma.
Zhanghuang C; Wang J; Yao Z; Li L; Xie Y; Tang H; Zhang K; Wu C; Yang Z; Yan B
Front Public Health; 2022; 10():874427. PubMed ID: 35444972
[TBL] [Abstract][Full Text] [Related]
27. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
[TBL] [Abstract][Full Text] [Related]
28. Construction and validation of a novel prognostic nomogram for patients with sarcomatoid renal cell carcinoma: a SEER-based study.
Hou G; Li X; Zheng Y; Liu P; Yan F; Ju D; Zhang G; Zheng W; Gao M; Hou N; Yuan J; Wang F; Yuan J
Int J Clin Oncol; 2020 Jul; 25(7):1356-1363. PubMed ID: 32361824
[TBL] [Abstract][Full Text] [Related]
29. Prognostic nomograms based on log odds of positive lymph nodes for patients with renal cell carcinoma: A retrospective cohort study.
Zhou W; Huang C; Yuan N
Int J Surg; 2018 Dec; 60():28-40. PubMed ID: 30389534
[TBL] [Abstract][Full Text] [Related]
30. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
Nuhn P; May M; Sun M; Fritsche HM; Brookman-May S; Buchner A; Bolenz C; Moritz R; Herrmann E; Burger M; Tilki D; Trojan L; Perrotte P; Haferkamp A; Hohenfellner M; Wieland WF; Müller SC; Karakiewicz PI; Bastian PJ
Eur Urol; 2012 Jan; 61(1):58-64. PubMed ID: 21840642
[TBL] [Abstract][Full Text] [Related]
31. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
Zhao E; Bai X
Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701
[TBL] [Abstract][Full Text] [Related]
32. Crafting a prognostic nomogram for the overall survival rate of cutaneous verrucous carcinoma using the surveillance, epidemiology, and end results database.
Chong S; Huang L; Yu H; Huang H; Ming WK; Ip CC; Mu HH; Li K; Zhang X; Lyu J; Deng L
Front Endocrinol (Lausanne); 2023; 14():1142014. PubMed ID: 37051207
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma.
Tan MH; Kanesvaran R; Li H; Tan HL; Tan PH; Wong CF; Chia KS; Teh BT; Yuen J; Chong TW
Urology; 2010 Jun; 75(6):1365-1370; 1370.e1-3. PubMed ID: 20022084
[TBL] [Abstract][Full Text] [Related]
34. Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma.
Rosiello G; Larcher A; Fallara G; Giancristofaro C; Martini A; Re C; Cei F; Musso G; Tian Z; Karakiewicz PI; Mottrie A; Bertini R; Salonia A; Necchi A; Raggi D; Briganti A; Montorsi F; Capitanio U
Urol Oncol; 2022 Jun; 40(6):271.e19-271.e27. PubMed ID: 35140049
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study.
Wang J; Zhanghuang C; Jin L; Zhang Z; Tan X; Mi T; Liu J; Li M; Wu X; Tian X; He D
BMC Geriatr; 2022 Sep; 22(1):736. PubMed ID: 36076163
[TBL] [Abstract][Full Text] [Related]
36. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
37. Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography.
Vis AN; Meijer D; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; Heymans MW; Nieuwenhuijzen JA; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Stricker P; Haynes AM; Oprea-Lager DE; Coughlin GD; van Leeuwen PJ
Eur Urol Oncol; 2023 Dec; 6(6):553-563. PubMed ID: 37045707
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients.
Borgmann H; Musquera M; Haferkamp A; Vilaseca A; Klatte T; Shariat SF; Scavuzzo A; Jimenez Rios MA; Wolff I; Capitanio U; Dell'Oglio P; Krabbe LM; Herrmann E; Ecke T; Vergho D; Huck N; Wagener N; Pahernik S; Zastrow S; Wirth M; Surcel C; Mirvald C; Prochazkova K; Hutterer G; Zigeuner R; Cindolo L; Hora M; Stief CG; May M; Brookman-May SD
World J Urol; 2017 Dec; 35(12):1891-1897. PubMed ID: 28836063
[TBL] [Abstract][Full Text] [Related]
39. External validation of the VENUSS prognostic model to predict recurrence after surgery in non-metastatic papillary renal cell carcinoma: A multi-institutional analysis.
Erdem S; Capitanio U; Campi R; Mir MC; Roussel E; Pavan N; Kara O; Klatte T; Kriegmair MC; Degirmenci E; Aydin R; Minervini A; Serni S; Berni A; Rebez G; Ozcan F;
Urol Oncol; 2022 May; 40(5):198.e9-198.e17. PubMed ID: 35172939
[TBL] [Abstract][Full Text] [Related]
40. Development and Validation of a Nomogram to Predict Distant Metastasis in Elderly Patients With Renal Cell Carcinoma.
Wang J; Zhanghuang C; Tan X; Mi T; Liu J; Jin L; Li M; Zhang Z; He D
Front Public Health; 2021; 9():831940. PubMed ID: 35155365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
